Blood test may predict cancer return in patients with limited spread
NCT ID NCT07426250
First seen Feb 26, 2026 · Last updated May 12, 2026 · Updated 10 times
Summary
This study is for people whose cancer has spread to just a few places in the body (oligometastatic disease) and who are getting treatment to destroy those spots. Researchers want to see if a blood test that looks for tumor DNA (ctDNA) can help predict if the cancer will come back or spread further. About 500 adults will give blood samples before, during, and after treatment, and their health will be followed over time. The goal is to learn whether ctDNA can be a useful early warning sign, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLIGOMETASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Oncology, Aarhus University Hospital
Aarhus N, 8200, Denmark
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.